Jim P Buttery
Affiliation: Royal Children's Hospital
- Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trialJim P Buttery
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Department of Paediatrics, University of Oxford, Churchill Hospital, Headington, Oxford, UK
JAMA 293:1751-8. 2005....
- Mass psychogenic response to human papillomavirus vaccinationJim P Buttery
SAEFVIC, Murdoch Childrens Research Institute, Royal Children s Hospital, and Department of Paediatrics, University of Melbourne, Melbourne, Vic, Australia
Med J Aust 189:261-2. 2008
- Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in AustraliaJ P Buttery
SAEFVIC in Child and Adolescent Immunisation, Murdoch Children s Research Institute, Parkville, Victoria 3052, Australia
Vaccine 29:3061-6. 2011..In Australia, post-marketing surveillance for intussusception following vaccination commenced with funding of RotaTeq(®) and Rotarix(®) vaccines under the National Immunization Program (NIP) in July 2007...
- A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide--CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phAnna Riddell
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Department of Paediatrics, University of Oxford, Churchill Hospital, Headington, Oxford OX3 7LJ, UK
Vaccine 25:3906-12. 2007..This study describes the persistence of immunity at 12 months of age and the immunologic response to a challenge dose of either meningococcal polysaccharide vaccine (Meningivac A+C; MnA+C), or MenC...
- Changes in the epidemiology of gastroenteritis in a paediatric short stay unit following the introduction of rotavirus immunisationJonathan D Akikusa
Department of General Medicine, Royal Children s Hospital, Melbourne, Victoria, Australia
J Paediatr Child Health 49:120-4. 2013..This study aimed to examine changes in the epidemiology of AGE in the SSU, and RCH overall, between 2005 and 2009 and explore whether this reflects a change specifically in AGE due to rotavirus...
- Identification of strains of RotaTeq rotavirus vaccine in infants with gastroenteritis following routine vaccinationCeleste M Donato
Enteric Virus Group, Murdoch Childrens Research Institute, Royal Children s Hospital, Melbourne, Australia
J Infect Dis 206:377-83. 2012..This study identified and characterised rotavirus strains excreted by infants who presented with symptoms of gastroenteritis following recent RotaTeq vaccination...
- Recurrent apnoea post immunisation: Informing re-immunisation policyVanessa Clifford
SAEFVIC, Murdoch Children s Research Institute, Melbourne, Australia
Vaccine 29:5681-7. 2011..The risk factors for, and recurrence rate of apnoea with subsequent immunisations are unknown, which makes planning for subsequent immunisations for these highly vulnerable infants difficult...
- Survivors of childhood cancer: an Australian audit of vaccination status after treatmentNigel W Crawford
NHMRC Centre for Clinical Research Excellence in Child and Adolescent Immunization, Parkville, Vic, Australia
Pediatr Blood Cancer 54:128-33. 2010..The aim of this study was to describe the compliance of post-chemotherapy revaccination of childhood cancer survivors relative to current Australian guidelines...
- An Australian audit of vaccination status in children and adolescents with inflammatory bowel diseaseNigel W Crawford
SAEFVIC, Department of General Medicine, Royal Children s Hospital RCH, Melbourne, Victoria 3011, Australia
BMC Gastroenterol 11:87. 2011..The primary aim of this study was to describe compliance with current Australian guidelines for vaccination of children and adolescents diagnosed with IBD. A secondary aim was to review the serological screening for VPD...
- Surveillance of adverse events following immunisation: the model of SAEFVIC, VictoriaHazel J Clothier
SAEFVIC, Murdoch Childrens Research Institute, Parkville, Victoria
Commun Dis Intell 35:294-8. 2011..6 per 100,000 in 2003 to 13.5 per 100,000 per annum in 2009. This report describes the SAEFVIC service model and summarises outcomes and lessons learnt in the first 3 years of operation...
- Syncope and seizures following human papillomavirus vaccination: a retrospective case seriesNigel W Crawford
Murdoch Childrens Research Institute, Melbourne, Vic, Australia
Med J Aust 194:16-8. 2011..To quantify and characterise the reports of syncope and seizures following quadrivalent (4v) human papillomavirus (HPV) vaccination...
- Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine scheduleJim P Buttery
Department of General Medicine and Murdoch Children s Research Institute, Royal Children s Hospital Melbourne, Parkville, Victoria, Australia Paediatric Infectious Diseases Unit, Monash Children s Hospital, Department of Paediatrics, Monash University, Melbourne, Victoria
Pediatr Infect Dis J 30:S25-9. 2011..This allowed comparison of both vaccines in similar populations with high infant vaccination coverage...
- Combination conjugate vaccinesNaor Bar-Zeev
Department of General Medicine, Royal Children s Hospital, Melbourne, Australia
Expert Opin Drug Saf 5:351-60. 2006..The implications of these findings for different communities are discussed, key areas for further research identified and implications for post-licensure monitoring addressed...
- Immunisation practices in infants born prematurely: neonatologists' survey and clinical auditNigel W Crawford
National Health and Medical Research Council NHMRC Centre for Clinical Research Excellence in Child and Adolescent Immunisation, Murdoch Children s Research Institute, Department of General Medicine, Royal Children s Hospital RCH, Parkville, Victoria, Australia
J Paediatr Child Health 45:602-9. 2009..To determine Australian neonatologists' recommendations for the immunisation of ex-preterm infants and compare their actual immunisation status with recommended Australian guidelines...
- Immunisation practices of paediatric oncologists: an Australasian surveyNigel W Crawford
NHMRC Centre for Clinical Research Excellence in Child and Adolescent Immunisation Murdoch Children s Research Institute, Royal Children s Hospital, Melbourne, Victoria, Australia
J Paediatr Child Health 43:593-6. 2007..The aim of this survey was to identify the current practices of paediatric oncologists in Australia and New Zealand regarding the immunisation of children treated for cancer...
- Mumps vaccine associated orchitis: Evidence supporting a potential immune-mediated mechanismVanessa Clifford
Infectious Diseases Unit, Department of General Medicine and Murdoch Childrens Research Institute, Royal Children s Hospital Melbourne, Parkville, Victoria 3052, Australia
Vaccine 28:2671-3. 2010..These cases, discussed together with a comprehensive review of the existing literature regarding post-vaccine orchitis, highlight uncertainty regarding the pathogenesis of post-vaccine orchitis...
- Human papillomavirus vaccine in boys: background rates of potential adverse eventsHazel J Clothier
Surveillance of Adverse Events Following Vaccination in the Community SAEFVIC, Murdoch Childrens Research Institute, Melbourne, Vic
Med J Aust 198:554-8. 2013..To determine background rates of potential adverse events following immunisation (AEFI) before expansion of the quadrivalent human papillomavirus (4vHPV) vaccination program to adolescent boys...
- Rotavirus vaccines in developed countriesJim P Buttery
NHMRC Centre of Clinical Research Excellence in Child and Adolescent Immunisation, Murdoch Children s Research Institute, Infectious Diseases Unit, Royal Children s Hospital, Parkville, Australia
Curr Opin Infect Dis 20:253-8. 2007..The recent licensure in many nations of vaccines against rotavirus offers promise to significantly reduce this toll. The present review describes recent developments regarding rotavirus vaccines and the challenges they face...
- Optimizing immunization in pediatric special risk groupsNigel W Crawford
SAEFVIC, Murdoch Childrens Research Institute, Melbourne, Australia
Expert Rev Vaccines 10:175-86. 2011..g., varicella, influenza and pertussis vaccination). Improving timeliness and minimizing missed opportunities to vaccinate individuals with these special risk conditions will also optimize protection from vaccine-preventable diseases...
- Recurrent 6th nerve palsy in a child following different live attenuated vaccines: case reportDaryl R Cheng
Central Medical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia
BMC Infect Dis 12:105. 2012..It has also been temporally associated with immunization, but has not been previously described following two different live attenuated vaccines...
- Complex regional pain syndrome following immunisationStephanie Richards
SAEFVIC, Department of General Medicine, Royal Children s Hospital RCH, Melbourne, Victoria, Australia
Arch Dis Child 97:913-5. 2012..Enhanced awareness of this syndrome and its potential to occur following immunisation in the paediatric population is vital to the prompt and effective management of this condition...
- Minimising missed opportunities to vaccinateNigel W Crawford
J Paediatr Child Health 44:315-6. 2008
- Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infantsClare L Collins
St George s Hospital Medical School, London, United Kingdom
Pediatr Infect Dis J 24:966-8. 2005..K. routine immunization schedule in 1999. This study is the first to describe both persistence of antibody and evidence for induction of immune memory using meningococcal C conjugate (MCC) vaccine in preterm infants...